...
首页> 外文期刊>Translational psychiatry. >Sex-specific depressive symptoms as markers of pre-Alzheimer dementia: findings from the Three-City cohort study
【24h】

Sex-specific depressive symptoms as markers of pre-Alzheimer dementia: findings from the Three-City cohort study

机译:性别特异性抑郁症状作为前阿尔茨海默痴呆症的标志:来自三城队列研究的调查结果

获取原文

摘要

Late-life depression, as a potential marker of pre-dementia, has seldom been explored by symptom dimension and sex, despite sexual dimorphic differences. This study aimed to examine whether specific depressive dimensions were associated with pre-Alzheimer's disease dementia (pre-AD), separately for women and men. Data were drawn from 5617 (58% women) community-dwellers aged 65+ recruited in 1999-2000 and followed at 2-year intervals for 12 years. We used Cox proportional hazard models to study associations between time-dependent Centre for Epidemiologic Studies-Depression Scale (CES-D) symptom dimensions (namely somatic, depressed, positive affect, and interpersonal challenge) and pre-AD, defined retrospectively from validated diagnoses established 3.5 (IQR: 3.2-4.0) years onwards. Analyses were performed according to overall depressive symptomatology (DS+: CES-D score?≥?16) and antidepressant/anxiolytic medication use (AA). Results indicated that in DS+?women only, all four dimensions were significantly associated with pre-AD in the AA- group, in particular somatic item 'Mind' and depressed affect items 'Depressed' and 'Blues'. The most depression-specific dimension, depressed affect, was also significantly associated with pre-AD in the DS- AA- women (HR:1.28, 95%CI: 1.12;1.47). In both sexes, in the DS- groups somatic affect was the most robust pre-AD marker, irrespective of treatment (women: HR?=?1.22, 95%CI: 1.08;1.38; men: HR?=?1.30, 95%CI: 1.14;1.48). Our findings highlight sex-specific associations between depressive symptom dimensions and pre-AD, modulated by depressive symptomatology and treatment. Assessment of specific symptom dimensions taking into account overall symptomatology and treatment could help identify and target high-risk AD-dementia profiles for interventions.
机译:尽管性二维差异,后期寿命抑郁症是症状维度和性别的潜在标志,很少被症状维度和性别探索。本研究旨在审查特定的抑郁尺寸是否与阿尔茨海默氏病痴呆(前ADP)有关,分别用于妇女和男性。从1999 - 2000年招募的65岁以上的5617名(58%女性)社区居民绘制了数据,并以2年的时间间隔为12年。我们使用Cox比例危险模型来研究流行病学研究 - 抑郁尺度(CES-D)症状尺寸(即躯体,抑郁,积极影响和人际关系挑战)和预先定义的验证性诊断中的时间依赖性中心之间的关联成立3.5(IQR:3.2-4.0)年份。根据整体抑郁症状(DS +:CES-D得分?≥≤16)和抗抑郁药/抗焦虑药物使用(AA)进行分析。结果表明,在DS +?女性中,所有四个维度都与AA集团的前广告有关,特别是躯体项“思维”和抑郁的影响物品“抑郁”和“蓝调”。最抑制的尺寸,抑郁的影响也与DS-AA - 女性的预涂量显着相关(HR:1.28,95%CI:1.12; 1.47)。在两性中,在DS - 群体中,躯体影响是最强大的预见标记,无论治疗如何(女性:HR?=?1.22,95%CI:1.08; 1.38;男人:HR?=?1.30,95% CI:1.14; 1.48)。我们的调查结果强调了抑郁症状尺寸和预涂前的性别的关联,通过抑郁症状和治疗调节。考虑到整体症状和治疗的特定症状尺寸的评估可以有助于识别和针对干预措施的高危痴呆症曲线。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号